サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：乾癬性関節炎治療市場- 成長、将来展望、競合分析、2023年～2031年
市場調査レポート
商品コード
1255973

乾癬性関節炎治療市場- 成長、将来展望、競合分析、2023年～2031年

Psoriatic Arthritis Treatment Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
出版日: | 発行: Acute Market Reports | ページ情報: 英文 119 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
乾癬性関節炎治療市場- 成長、将来展望、競合分析、2023年～2031年
出版日: 2023年01月30日
発行: Acute Market Reports
ページ情報: 英文 119 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

乾癬性関節炎治療市場は2023年から2031年にかけてCAGR7.5%で拡大すると予測される関節炎財団は、乾癬性関節炎を主に皮膚を侵す自己免疫性炎症性疾患と定義しています。乾癬に罹患している患者の30%は、乾癬の後期に関節炎を発症すると言われています。乾癬性関節炎は男女を問わず発症し、世界の有病率は10万人あたり6人とされています。この疾患は異質な疾患であり、5つのサブタイプ、すなわち、対称性乾癬性関節炎、非対称性乾癬性関節炎、遠位乾癬性関節炎、脊椎炎、関節炎変異型に分類されます。乾癬性関節炎治療市場を牽引する要因は、皮膚疾患に関する公衆衛生意識の高まり、疾患の早期診断、そして近年のインターロイキン17阻害剤の開発です。発症は北米と欧州の白人集団に多く、次いでアジア太平洋地域が多いです。

国際乾癬協会連盟（IFPA）の2016年の統計によると、世界中で約1億2,500万人が乾癬性関節炎に悩まされています。乾癬性関節炎の診断は、患者さんに腱鞘炎、炎症性脊椎痛、乳突炎などの症状があるため複雑であり、関節炎と誤解されることがほとんどです。現在、関節症性乾癬に処方される薬剤は、軽症、中等症、重症の関節症性乾癬など、重症度によって分けられています。secukinumab、ixekizumab、brodalumabなどのInterleukin-17阻害剤の開発は、より優れた薬物安全性と有効性を有する関節症性乾癬の治療薬として注目されています。ABT-494（Abbvie, Inc.）とAprelimast（Celgene Corporation）、Certolizumab Pegol（UCB BIOSCIENCES GmbH）は標的治療薬として開発中で、2022年から2030年の予測期間中に発売され乾癬性関節炎治療市場を資本化すると考えられています。

目次

第1章 序文

  • レポート内容
    • 報告書の目的
    • 対象読者
    • 主な提供商品
  • 市場セグメンテーション
  • 調査手法
    • フェーズⅠ-二次調査
    • フェーズⅡ-一次調査
    • フェーズⅢ-有識者別レビュー
    • 前提条件
    • 採用したアプローチ

第2章 エグゼクティブサマリー

  • 市場のスナップショット：世界の乾癬性関節炎治療市場
  • 世界の乾癬性関節炎治療市場：薬物クラス別 2022
  • 世界の乾癬性関節炎治療市場：投与経路別 2022
  • 世界の乾癬性関節炎治療市場：流通チャネル別 2022
  • 世界の乾癬性関節炎治療市場：地域別 2022
  • 魅力的な投資提案：地域別 2022

第3章 乾癬性関節炎治療市場：競合分析

  • 主要ベンダーの市場ポジショニング
  • ベンダーが採用する戦略
  • 主要な産業戦略
  • ティア分析：2022 Versus 2031

第4章 乾癬性関節炎治療市場：マクロ分析と市場力学

  • イントロダクション
  • 世界の乾癬性関節炎治療市場価値 2021-2031
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進要因とレストレイントの影響分析
  • シーソー分析

第5章 乾癬性関節炎治療市場：薬物クラス別 2021-2031

  • 市場概要
  • 成長・収益分析：2022 Versus 2031
  • 市場セグメンテーション
    • TNF阻害剤
    • インターロイキン阻害剤
    • PDE4阻害剤
    • その他

第6章 乾癬性関節炎治療市場：投与経路別 2021-2031

  • 市場概要
  • 成長・収益分析：2022 Versus 2031
  • 市場セグメンテーション
    • オーラル
    • 非経口
    • 話題の

第7章 乾癬性関節炎治療市場：流通チャネル別 2021-2031

  • 市場概要
  • 成長・収益分析：2022 Versus 2031
  • 市場セグメンテーション
    • 病院薬局
    • 小売薬局
    • オンライン薬局

第8章 北米乾癬性関節炎治療市場 2021-2031

  • 市場概要
  • 乾癬性関節炎治療市場：薬物クラス別 2021-2031
  • 乾癬性関節炎治療市場：投与経路別 2021-2031
  • 乾癬性関節炎治療市場：流通チャネル別 2021-2031
  • 乾癬性関節炎治療市場：地域別 2021-2031
    • 北米
      • 米国
      • カナダ
      • その他北米地域

第9章 英国と欧州連合乾癬性関節炎治療市場 2021-2031

  • 市場概要
  • 乾癬性関節炎治療市場：薬物クラス別 2021-2031
  • 乾癬性関節炎治療市場：投与経路別 2021-2031
  • 乾癬性関節炎治療市場：流通チャネル別 2021-2031
  • 乾癬性関節炎治療市場：地域別 2021-2031
    • 英国と欧州連合
      • 英国
      • ドイツ
      • スペイン
      • イタリア
      • フランス
      • その他欧州地域

第10章 アジア太平洋乾癬性関節炎治療市場 2021-2031

  • 市場概要
  • 乾癬性関節炎治療市場：薬物クラス別 2021-2031
  • 乾癬性関節炎治療市場：投与経路別 2021-2031
  • 乾癬性関節炎治療市場：流通チャネル別 2021-2031
  • 乾癬性関節炎治療市場：地域別 2021-2031
    • アジア太平洋
      • 中国
      • 日本
      • インド
      • オーストラリア
      • 韓国
      • その他アジア太平洋地域

第11章 ラテンアメリカ乾癬性関節炎治療市場 2021-2031

  • 市場概要
  • 乾癬性関節炎治療市場：薬物クラス別 2021-2031
  • 乾癬性関節炎治療市場：投与経路別 2021-2031
  • 乾癬性関節炎治療市場：流通チャネル別 2021-2031
  • 乾癬性関節炎治療市場：地域別 2021-2031
    • ラテンアメリカ
      • ブラジル
      • メキシコ
      • その他ラテンアメリカ地域

第12章 中東・アフリカ乾癬性関節炎治療市場 2021-2031

  • 市場概要
  • 乾癬性関節炎治療市場：薬物クラス別 2021-2031
  • 乾癬性関節炎治療市場：投与経路別 2021-2031
  • 乾癬性関節炎治療市場：流通チャネル別 2021-2031
  • 乾癬性関節炎治療市場：地域別 2021-2031
    • 中東・アフリカ
      • GCC
      • アフリカ
      • その他中東・アフリカ地域

第13章 企業プロファイル

  • Abbvie Inc.
  • Amgen Inc.
  • Bristol Myers Squibb Company
  • Celgene Corporation
  • Eli Lilly and Company
  • F.Hoffman La-Roche AG
  • Janssen Global Services
  • Merck & Co.
  • Novartis AG
  • Valeant Pharmaceuticals International Inc.
  • その他
図表

List of Tables

  • TABLE 1 Global Psoriatic Arthritis Treatment Market By Drug Class, 2021-2031, USD (Million)
  • TABLE 2 Global Psoriatic Arthritis Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 3 Global Psoriatic Arthritis Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 4 North America Psoriatic Arthritis Treatment Market By Drug Class, 2021-2031, USD (Million)
  • TABLE 5 North America Psoriatic Arthritis Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 6 North America Psoriatic Arthritis Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 7 U.S. Psoriatic Arthritis Treatment Market By Drug Class, 2021-2031, USD (Million)
  • TABLE 8 U.S. Psoriatic Arthritis Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 9 U.S. Psoriatic Arthritis Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 10 Canada Psoriatic Arthritis Treatment Market By Drug Class, 2021-2031, USD (Million)
  • TABLE 11 Canada Psoriatic Arthritis Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 12 Canada Psoriatic Arthritis Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 13 Rest of North America Psoriatic Arthritis Treatment Market By Drug Class, 2021-2031, USD (Million)
  • TABLE 14 Rest of North America Psoriatic Arthritis Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 15 Rest of North America Psoriatic Arthritis Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 16 UK and European Union Psoriatic Arthritis Treatment Market By Drug Class, 2021-2031, USD (Million)
  • TABLE 17 UK and European Union Psoriatic Arthritis Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 18 UK and European Union Psoriatic Arthritis Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 19 UK Psoriatic Arthritis Treatment Market By Drug Class, 2021-2031, USD (Million)
  • TABLE 20 UK Psoriatic Arthritis Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 21 UK Psoriatic Arthritis Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 22 Germany Psoriatic Arthritis Treatment Market By Drug Class, 2021-2031, USD (Million)
  • TABLE 23 Germany Psoriatic Arthritis Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 24 Germany Psoriatic Arthritis Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 25 Spain Psoriatic Arthritis Treatment Market By Drug Class, 2021-2031, USD (Million)
  • TABLE 26 Spain Psoriatic Arthritis Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 27 Spain Psoriatic Arthritis Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 28 Italy Psoriatic Arthritis Treatment Market By Drug Class, 2021-2031, USD (Million)
  • TABLE 29 Italy Psoriatic Arthritis Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 30 Italy Psoriatic Arthritis Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 31 France Psoriatic Arthritis Treatment Market By Drug Class, 2021-2031, USD (Million)
  • TABLE 32 France Psoriatic Arthritis Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 33 France Psoriatic Arthritis Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 34 Rest of Europe Psoriatic Arthritis Treatment Market By Drug Class, 2021-2031, USD (Million)
  • TABLE 35 Rest of Europe Psoriatic Arthritis Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 36 Rest of Europe Psoriatic Arthritis Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 37 Asia Psoriatic Arthritis Treatment Market By Drug Class, 2021-2031, USD (Million)
  • TABLE 38 Asia Psoriatic Arthritis Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 39 Asia Psoriatic Arthritis Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 40 China Psoriatic Arthritis Treatment Market By Drug Class, 2021-2031, USD (Million)
  • TABLE 41 China Psoriatic Arthritis Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 42 China Psoriatic Arthritis Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 43 Japan Psoriatic Arthritis Treatment Market By Drug Class, 2021-2031, USD (Million)
  • TABLE 44 Japan Psoriatic Arthritis Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 45 Japan Psoriatic Arthritis Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 46 India Psoriatic Arthritis Treatment Market By Drug Class, 2021-2031, USD (Million)
  • TABLE 47 India Psoriatic Arthritis Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 48 India Psoriatic Arthritis Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 49 Australia Psoriatic Arthritis Treatment Market By Drug Class, 2021-2031, USD (Million)
  • TABLE 50 Australia Psoriatic Arthritis Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 51 Australia Psoriatic Arthritis Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 52 South Korea Psoriatic Arthritis Treatment Market By Drug Class, 2021-2031, USD (Million)
  • TABLE 53 South Korea Psoriatic Arthritis Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 54 South Korea Psoriatic Arthritis Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 55 Latin America Psoriatic Arthritis Treatment Market By Drug Class, 2021-2031, USD (Million)
  • TABLE 56 Latin America Psoriatic Arthritis Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 57 Latin America Psoriatic Arthritis Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 58 Brazil Psoriatic Arthritis Treatment Market By Drug Class, 2021-2031, USD (Million)
  • TABLE 59 Brazil Psoriatic Arthritis Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 60 Brazil Psoriatic Arthritis Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 61 Mexico Psoriatic Arthritis Treatment Market By Drug Class, 2021-2031, USD (Million)
  • TABLE 62 Mexico Psoriatic Arthritis Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 63 Mexico Psoriatic Arthritis Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 64 Rest of Latin America Psoriatic Arthritis Treatment Market By Drug Class, 2021-2031, USD (Million)
  • TABLE 65 Rest of Latin America Psoriatic Arthritis Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 66 Rest of Latin America Psoriatic Arthritis Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 67 Middle East and Africa Psoriatic Arthritis Treatment Market By Drug Class, 2021-2031, USD (Million)
  • TABLE 68 Middle East and Africa Psoriatic Arthritis Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 69 Middle East and Africa Psoriatic Arthritis Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 70 GCC Psoriatic Arthritis Treatment Market By Drug Class, 2021-2031, USD (Million)
  • TABLE 71 GCC Psoriatic Arthritis Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 72 GCC Psoriatic Arthritis Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 73 Africa Psoriatic Arthritis Treatment Market By Drug Class, 2021-2031, USD (Million)
  • TABLE 74 Africa Psoriatic Arthritis Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 75 Africa Psoriatic Arthritis Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 76 Rest of Middle East and Africa Psoriatic Arthritis Treatment Market By Drug Class, 2021-2031, USD (Million)
  • TABLE 77 Rest of Middle East and Africa Psoriatic Arthritis Treatment Market By Route of Administration, 2021-2031, USD (Million)
  • TABLE 78 Rest of Middle East and Africa Psoriatic Arthritis Treatment Market By Distribution Channel, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global Psoriatic Arthritis Treatment Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Psoriatic Arthritis Treatment Market: Quality Assurance
  • FIG. 5 Global Psoriatic Arthritis Treatment Market, By Drug Class, 2022
  • FIG. 6 Global Psoriatic Arthritis Treatment Market, By Route of Administration, 2022
  • FIG. 7 Global Psoriatic Arthritis Treatment Market, By Distribution Channel, 2022
  • FIG. 8 Global Psoriatic Arthritis Treatment Market, By Geography, 2022
  • FIG. 9 Market Geographical Opportunity Matrix - Global Psoriatic Arthritis Treatment Market, 2022
  • FIG. 10 Market Positioning of Key Psoriatic Arthritis Treatment Market Players, 2022
  • FIG. 11 Global Psoriatic Arthritis Treatment Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
  • FIG. 12 Global Psoriatic Arthritis Treatment Market, By Drug Class, 2022 Vs 2031, %
  • FIG. 13 Global Psoriatic Arthritis Treatment Market, By Route of Administration, 2022 Vs 2031, %
  • FIG. 14 Global Psoriatic Arthritis Treatment Market, By Distribution Channel, 2022 Vs 2031, %
  • FIG. 15 U.S. Psoriatic Arthritis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 16 Canada Psoriatic Arthritis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 17 Rest of North America Psoriatic Arthritis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 18 UK Psoriatic Arthritis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 19 Germany Psoriatic Arthritis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 20 Spain Psoriatic Arthritis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 21 Italy Psoriatic Arthritis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 22 France Psoriatic Arthritis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 23 Rest of Europe Psoriatic Arthritis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 24 China Psoriatic Arthritis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 25 Japan Psoriatic Arthritis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 26 India Psoriatic Arthritis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 27 Australia Psoriatic Arthritis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 28 South Korea Psoriatic Arthritis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 29 Rest of Asia Psoriatic Arthritis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 30 Brazil Psoriatic Arthritis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 31 Mexico Psoriatic Arthritis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 32 Rest of Latin America Psoriatic Arthritis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 33 GCC Psoriatic Arthritis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 34 Africa Psoriatic Arthritis Treatment Market (US$ Million), 2021 - 2031
  • FIG. 35 Rest of Middle East and Africa Psoriatic Arthritis Treatment Market (US$ Million), 2021 - 2031
目次
Product Code: 138008-01-23

Psoriatic Arthritis Treatment Market Is Projected to Expand At A CAGR Of 7.5% Between 2023 And 2031. The Arthritis Foundation defines psoriatic arthritis as an autoimmune inflammatory disease that primarily affects the skin. Majorly 30% of the patients suffering from psoriasis develop psoriatic arthritis during the later stages of the disease. Psoriatic arthritis affects men and women equally with a global prevalence rate of 6 per 100,000 people. It is a heterogeneous disease and is categorized into 5 subtypes, namely, symmetric psoriatic arthritis, asymmetric psoriatic arthritis, distal psoriatic arthritis, spondylitis, and arthritis mutilans. The factors driving the psoriatic arthritis treatment market are rising public health awareness regarding skin diseases, early disease diagnosis, and the recent development of interleukin-17 inhibitors. The occurrence is high in the Caucasian populations of North America and Europe followed by Asia Pacific.

According to the International Federation of Psoriasis Associations (IFPA) 2016 statistics, around 125 million people throughout the globe are suffering from psoriatic arthritis. The diagnosis of psoriatic arthritis is complex due to the presence of symptoms in patients such as tendinitis, inflammatory spinal pain, or dactylitis, which are most often misunderstood as arthritis. Currently, the drugs prescribed for psoriatic arthritis are based on the severity of the disease such as mild, moderate, or severe psoriatic arthritis. The development of Interleukin-17 inhibitors such as secukinumab, ixekizumab, and brodalumab have better drug safety and efficacy for the treatment of psoriatic arthritis. ABT-494 (Abbvie, Inc.) and Aprelimast (Celgene Corporation), and Certolizumab Pegol (UCB BIOSCIENCES GmbH) are being developed as targeted therapies and are set to launch during the forecast period from 2022 to 2030 and capitalize the psoriatic arthritis treatment market.

Key players identified for the psoriatic arthritis treatment market include:

Abbvie, Inc., Amgen, Inc., Bristol Myers Squibb Company, Celgene Corporation, Eli Lilly and Company, F.Hoffman La-Roche AG, Janssen Global Services, Merck & Co., Novartis AG, Valeant Pharmaceuticals International, Inc. and Others.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Psoriatic Arthritis Treatment market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Psoriatic Arthritis Treatment market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Drug Class

TNF Inhibitors

Interleukin Inhibitors

PDE4 Inhibitors

Others

Route of Administration

Oral

Parenteral

Topical

Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Region Segment (2021-2031; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of Psoriatic Arthritis Treatment market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2031.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Psoriatic Arthritis Treatment market?

Which is the largest regional market for Psoriatic Arthritis Treatment market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Psoriatic Arthritis Treatment market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Psoriatic Arthritis Treatment market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Psoriatic Arthritis Treatment Market
  • 2.2. Global Psoriatic Arthritis Treatment Market, By Drug Class, 2022 (US$ Million)
  • 2.3. Global Psoriatic Arthritis Treatment Market, By Route of Administration, 2022 (US$ Million)
  • 2.4. Global Psoriatic Arthritis Treatment Market, By Distribution Channel, 2022 (US$ Million)
  • 2.5. Global Psoriatic Arthritis Treatment Market, By Geography, 2022 (US$ Million)
  • 2.6. Attractive Investment Proposition by Geography, 2022

3. Psoriatic Arthritis Treatment Market: Competitive Analysis

  • 3.1. Market Positioning of Key Psoriatic Arthritis Treatment Market Vendors
  • 3.2. Strategies Adopted by Psoriatic Arthritis Treatment Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Psoriatic Arthritis Treatment Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Psoriatic Arthritis Treatment Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Psoriatic Arthritis Treatment Market: By Drug Class, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. TNF Inhibitors
    • 5.3.2. Interleukin Inhibitors
    • 5.3.3. PDE4 Inhibitors
    • 5.3.4. Others

6. Psoriatic Arthritis Treatment Market: By Route of Administration, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Oral
    • 6.3.2. Parenteral
    • 6.3.3. Topical

7. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 7.3. Market Segmentation
    • 7.3.1. Hospital Pharmacies
    • 7.3.2. Retail Pharmacies
    • 7.3.3. Online Pharmacies

8. North America Psoriatic Arthritis Treatment Market, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Psoriatic Arthritis Treatment Market: By Drug Class, 2021-2031, USD (Million)
  • 8.3. Psoriatic Arthritis Treatment Market: By Route of Administration, 2021-2031, USD (Million)
  • 8.4. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
  • 8.5.Psoriatic Arthritis Treatment Market: By Region, 2021-2031, USD (Million)
    • 8.5.1.North America
      • 8.5.1.1. U.S.
        • 8.5.1.1.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2021-2031, USD (Million)
        • 8.5.1.1.1. Psoriatic Arthritis Treatment Market: By Route of Administration, 2021-2031, USD (Million)
        • 8.5.1.1.1. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
      • 8.5.1.2. Canada
        • 8.5.1.2.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2021-2031, USD (Million)
        • 8.5.1.2.1. Psoriatic Arthritis Treatment Market: By Route of Administration, 2021-2031, USD (Million)
        • 8.5.1.2.1. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
      • 8.5.1.3. Rest of North America
        • 8.5.1.3.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2021-2031, USD (Million)
        • 8.5.1.3.1. Psoriatic Arthritis Treatment Market: By Route of Administration, 2021-2031, USD (Million)
        • 8.5.1.3.1. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2021-2031, USD (Million)

9. UK and European Union Psoriatic Arthritis Treatment Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Psoriatic Arthritis Treatment Market: By Drug Class, 2021-2031, USD (Million)
  • 9.3. Psoriatic Arthritis Treatment Market: By Route of Administration, 2021-2031, USD (Million)
  • 9.4. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
  • 9.5.Psoriatic Arthritis Treatment Market: By Region, 2021-2031, USD (Million)
    • 9.5.1.UK and European Union
      • 9.5.1.1. UK
        • 9.5.1.1.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2021-2031, USD (Million)
        • 9.5.1.1.1. Psoriatic Arthritis Treatment Market: By Route of Administration, 2021-2031, USD (Million)
        • 9.5.1.1.1. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
      • 9.5.1.2. Germany
        • 9.5.1.2.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2021-2031, USD (Million)
        • 9.5.1.2.1. Psoriatic Arthritis Treatment Market: By Route of Administration, 2021-2031, USD (Million)
        • 9.5.1.2.1. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
      • 9.5.1.3. Spain
        • 9.5.1.3.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2021-2031, USD (Million)
        • 9.5.1.3.1. Psoriatic Arthritis Treatment Market: By Route of Administration, 2021-2031, USD (Million)
        • 9.5.1.3.1. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
      • 9.5.1.4. Italy
        • 9.5.1.4.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2021-2031, USD (Million)
        • 9.5.1.4.1. Psoriatic Arthritis Treatment Market: By Route of Administration, 2021-2031, USD (Million)
        • 9.5.1.4.1. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
      • 9.5.1.5. France
        • 9.5.1.5.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2021-2031, USD (Million)
        • 9.5.1.5.1. Psoriatic Arthritis Treatment Market: By Route of Administration, 2021-2031, USD (Million)
        • 9.5.1.5.1. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
      • 9.5.1.6. Rest of Europe
        • 9.5.1.6.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2021-2031, USD (Million)
        • 9.5.1.6.1. Psoriatic Arthritis Treatment Market: By Route of Administration, 2021-2031, USD (Million)
        • 9.5.1.6.1. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2021-2031, USD (Million)

10. Asia Pacific Psoriatic Arthritis Treatment Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Psoriatic Arthritis Treatment Market: By Drug Class, 2021-2031, USD (Million)
  • 10.3. Psoriatic Arthritis Treatment Market: By Route of Administration, 2021-2031, USD (Million)
  • 10.4. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
  • 10.5.Psoriatic Arthritis Treatment Market: By Region, 2021-2031, USD (Million)
    • 10.5.1.Asia Pacific
      • 10.5.1.1. China
        • 10.5.1.1.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2021-2031, USD (Million)
        • 10.5.1.1.1. Psoriatic Arthritis Treatment Market: By Route of Administration, 2021-2031, USD (Million)
        • 10.5.1.1.1. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
      • 10.5.1.2. Japan
        • 10.5.1.2.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2021-2031, USD (Million)
        • 10.5.1.2.1. Psoriatic Arthritis Treatment Market: By Route of Administration, 2021-2031, USD (Million)
        • 10.5.1.2.1. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
      • 10.5.1.3. India
        • 10.5.1.3.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2021-2031, USD (Million)
        • 10.5.1.3.1. Psoriatic Arthritis Treatment Market: By Route of Administration, 2021-2031, USD (Million)
        • 10.5.1.3.1. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
      • 10.5.1.4. Australia
        • 10.5.1.4.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2021-2031, USD (Million)
        • 10.5.1.4.1. Psoriatic Arthritis Treatment Market: By Route of Administration, 2021-2031, USD (Million)
        • 10.5.1.4.1. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
      • 10.5.1.5. South Korea
        • 10.5.1.5.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2021-2031, USD (Million)
        • 10.5.1.5.1. Psoriatic Arthritis Treatment Market: By Route of Administration, 2021-2031, USD (Million)
        • 10.5.1.5.1. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
      • 10.5.1.6. Rest of Asia Pacific
        • 10.5.1.6.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2021-2031, USD (Million)
        • 10.5.1.6.1. Psoriatic Arthritis Treatment Market: By Route of Administration, 2021-2031, USD (Million)
        • 10.5.1.6.1. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2021-2031, USD (Million)

11. Latin America Psoriatic Arthritis Treatment Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Psoriatic Arthritis Treatment Market: By Drug Class, 2021-2031, USD (Million)
  • 11.3. Psoriatic Arthritis Treatment Market: By Route of Administration, 2021-2031, USD (Million)
  • 11.4. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
  • 11.5.Psoriatic Arthritis Treatment Market: By Region, 2021-2031, USD (Million)
    • 11.5.1.Latin America
      • 11.5.1.1. Brazil
        • 11.5.1.1.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2021-2031, USD (Million)
        • 11.5.1.1.1. Psoriatic Arthritis Treatment Market: By Route of Administration, 2021-2031, USD (Million)
        • 11.5.1.1.1. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
      • 11.5.1.2. Mexico
        • 11.5.1.2.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2021-2031, USD (Million)
        • 11.5.1.2.1. Psoriatic Arthritis Treatment Market: By Route of Administration, 2021-2031, USD (Million)
        • 11.5.1.2.1. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
      • 11.5.1.3. Rest of Latin America
        • 11.5.1.3.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2021-2031, USD (Million)
        • 11.5.1.3.1. Psoriatic Arthritis Treatment Market: By Route of Administration, 2021-2031, USD (Million)
        • 11.5.1.3.1. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2021-2031, USD (Million)

12. Middle East and Africa Psoriatic Arthritis Treatment Market, 2021-2031, USD (Million)

  • 12.1. Market Overview
  • 12.2. Psoriatic Arthritis Treatment Market: By Drug Class, 2021-2031, USD (Million)
  • 12.3. Psoriatic Arthritis Treatment Market: By Route of Administration, 2021-2031, USD (Million)
  • 12.4. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
  • 12.5.Psoriatic Arthritis Treatment Market: By Region, 2021-2031, USD (Million)
    • 12.5.1.Middle East and Africa
      • 12.5.1.1. GCC
        • 12.5.1.1.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2021-2031, USD (Million)
        • 12.5.1.1.1. Psoriatic Arthritis Treatment Market: By Route of Administration, 2021-2031, USD (Million)
        • 12.5.1.1.1. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
      • 12.5.1.2. Africa
        • 12.5.1.2.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2021-2031, USD (Million)
        • 12.5.1.2.1. Psoriatic Arthritis Treatment Market: By Route of Administration, 2021-2031, USD (Million)
        • 12.5.1.2.1. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
      • 12.5.1.3. Rest of Middle East and Africa
        • 12.5.1.3.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2021-2031, USD (Million)
        • 12.5.1.3.1. Psoriatic Arthritis Treatment Market: By Route of Administration, 2021-2031, USD (Million)
        • 12.5.1.3.1. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2021-2031, USD (Million)

13. Company Profile

  • 13.1. Abbvie, Inc.
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Portfolio
    • 13.1.4. Strategic Initiatives
  • 13.2. Amgen, Inc.
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Portfolio
    • 13.2.4. Strategic Initiatives
  • 13.3. Bristol Myers Squibb Company
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Portfolio
    • 13.3.4. Strategic Initiatives
  • 13.4. Celgene Corporation
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Portfolio
    • 13.4.4. Strategic Initiatives
  • 13.5. Eli Lilly and Company
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Portfolio
    • 13.5.4. Strategic Initiatives
  • 13.6. F.Hoffman La-Roche AG
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Portfolio
    • 13.6.4. Strategic Initiatives
  • 13.7. Janssen Global Services
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Portfolio
    • 13.7.4. Strategic Initiatives
  • 13.8. Merck & Co.
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Portfolio
    • 13.8.4. Strategic Initiatives
  • 13.9. Novartis AG
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Portfolio
    • 13.9.4. Strategic Initiatives
  • 13.10. Valeant Pharmaceuticals International, Inc.
    • 13.10.1. Company Overview
    • 13.10.2. Financial Performance
    • 13.10.3. Product Portfolio
    • 13.10.4. Strategic Initiatives
  • 13.11. Others
    • 13.11.1. Company Overview
    • 13.11.2. Financial Performance
    • 13.11.3. Product Portfolio
    • 13.11.4. Strategic Initiatives